Tarceva
/
Tarceva (erlotinib) is an oral medication classified as a tyrosine kinase inhibitor, primarily used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It is available as an oral tablet and is a prescription-only medication. Patients are advised that Tarceva may cause serious side effects, including interstitial lung disease, and should not be used in patients with a history of severe hypersensitivity to erlotinib or any of its components.
Interactions
Omeprazole: May decrease the plasma concentration of erlotinib, potentially reducing its effectiveness. It is advised to avoid concomitant use.
Warfarin: Erlotinib may increase the anticoagulant effect of warfarin, leading to an increased risk of bleeding. Monitoring of INR is recommended.
Grapefruit juice: Consumption may increase the plasma concentration of erlotinib, which could enhance its effects and side effects. It is recommended to avoid grapefruit juice.
25
commonly-prescribed
medication.